"Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation" was originally created and published by Medical ...
Pulsenmore’s FDA-approved home ultrasound device allows pregnant women to perform scans from home, revolutionizing pregnancy ...
Based on these scans, clinicians are able to assess fetal heartbeat, fetal movements, and amniotic fluid volume.
Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) ...